SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.345+2.7%Jan 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sds who wrote (369)8/18/1997 4:06:00 PM
From: Bottom_Dweller   of 3578
 
So, while you are certainly right that commercialization is a tiny blip on the horizon, I don't think you can say that their technology has no commercial value simply because they published their results in such a highly respected journal as Science.

The fact that they published it in Science and whether something is eventually commercial aren't tied at all, granted. My intention wasn't to make that assertion, merely to say that the news release was much more of a research topic one than one that should cause a stock to increase by 270%.

Will GERN make revenue with it? Who knows looks very doubtful in the short term, their stock certainly has made them some money, however...

Cheers!

Kyle..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext